BRPI1010748A2 - comprimidos de ibuprofeno sódico e métodos para produzir composições farmacêuticas incluindo ibupofreno sódico. - Google Patents

comprimidos de ibuprofeno sódico e métodos para produzir composições farmacêuticas incluindo ibupofreno sódico.

Info

Publication number
BRPI1010748A2
BRPI1010748A2 BRPI1010748A BRPI1010748A BRPI1010748A2 BR PI1010748 A2 BRPI1010748 A2 BR PI1010748A2 BR PI1010748 A BRPI1010748 A BR PI1010748A BR PI1010748 A BRPI1010748 A BR PI1010748A BR PI1010748 A2 BRPI1010748 A2 BR PI1010748A2
Authority
BR
Brazil
Prior art keywords
sodium
ibupofrene
methods
pharmaceutical compositions
compositions including
Prior art date
Application number
BRPI1010748A
Other languages
English (en)
Inventor
Amy L Conder
Angela P Taylor
Bonny Rene Shaw
Jeffery J Seyer
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI1010748A2 publication Critical patent/BRPI1010748A2/pt
Publication of BRPI1010748B1 publication Critical patent/BRPI1010748B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BRPI1010748-7A 2009-06-22 2010-06-21 Composição farmacêutica compreendendo ibuprofeno sódico dihidratado BRPI1010748B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21914909P 2009-06-22 2009-06-22
US61/219.149 2009-06-22
PCT/US2010/039346 WO2011005478A2 (en) 2009-06-22 2010-06-21 Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen

Publications (2)

Publication Number Publication Date
BRPI1010748A2 true BRPI1010748A2 (pt) 2016-03-22
BRPI1010748B1 BRPI1010748B1 (pt) 2026-01-27

Family

ID=

Also Published As

Publication number Publication date
SG10201509312UA (en) 2015-12-30
ZA201109501B (en) 2012-09-26
TWI542344B (zh) 2016-07-21
HK1213783A1 (zh) 2016-07-15
US20100323005A1 (en) 2010-12-23
JP6446413B2 (ja) 2018-12-26
AU2010270976B2 (en) 2014-03-20
ES2654331T3 (es) 2018-02-13
IL253975A0 (en) 2017-10-31
NZ628603A (en) 2016-04-29
JP2016222696A (ja) 2016-12-28
RU2715680C2 (ru) 2020-03-03
US20200009093A1 (en) 2020-01-09
TW201318622A (zh) 2013-05-16
RU2011150661A (ru) 2013-07-27
CN102802613A (zh) 2012-11-28
TWI504393B (zh) 2015-10-21
US20170319518A1 (en) 2017-11-09
IL216602B (en) 2019-09-26
MX347467B (es) 2017-04-26
KR101429331B1 (ko) 2014-08-11
TW201521717A (zh) 2015-06-16
RU2015122313A (ru) 2018-12-20
CN104922084A (zh) 2015-09-23
CA2764740C (en) 2015-09-01
AU2010270976A1 (en) 2011-12-15
MX374707B (es) 2025-03-06
RU2019140368A (ru) 2021-06-09
MX2011013912A (es) 2012-02-23
KR20120026559A (ko) 2012-03-19
HUE037827T2 (hu) 2018-09-28
PL2445486T3 (pl) 2018-04-30
WO2011005478A2 (en) 2011-01-13
TW201110964A (en) 2011-04-01
KR20140053414A (ko) 2014-05-07
RU2015122313A3 (pt) 2018-12-21
CA2764740A1 (en) 2011-01-13
TWI477270B (zh) 2015-03-21
NZ620828A (en) 2014-08-29
PT2445486T (pt) 2018-01-03
IL216602A0 (en) 2012-02-29
CO6480926A2 (es) 2012-07-16
CN104922084B (zh) 2020-01-14
SG176221A1 (en) 2012-01-30
JP2012530781A (ja) 2012-12-06
EP2445486A2 (en) 2012-05-02
US20150231099A1 (en) 2015-08-20
EP2445486B1 (en) 2017-11-08
AR077189A1 (es) 2011-08-10
WO2011005478A3 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
LTPA2020003I1 (lt) Dvisluoksnės tabletės formuluotės
DK2395834T3 (da) Natriumnitrit-holdige farmaceutiske sammensætninger
EP2451274A4 (en) Pharmaceutical compositions
EP2419097A4 (en) PHARMACEUTICAL COMPOSITIONS
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
BRPI1004940A2 (pt) composição farmacêutica
SMT201700095B (is) Composizioni farmaceutiche per inalazione
BR112012011733A2 (pt) formulações de comprimido de liberação imediata
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BRPI1012875A2 (pt) composições farmacêuticas sólidas e processos para sua produção
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
BR112012012108A2 (pt) composição farmacêutica compreendendo propofol
DK3061445T3 (da) Højkoncentrerede farmaceutiske formuleringer
SMT201400069B (it) Formulazione farmaceutica
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BRPI1016190A2 (pt) compostos farmacêuticos.
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
IT1394400B1 (it) Composizioni farmaceutiche
BRPI1011412A2 (pt) composição para liberação sustentada de droga compreendendo alutinante geopolimérico
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BRPI0918539A2 (pt) preparação farmacêutica sólida para administração oral
BR112012003149A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25G Requested change of headquarter approved

Owner name: WYETH LLC (US)

B25A Requested transfer of rights approved

Owner name: PF CONSUMER HEALTHCARE 1 LLC (US)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/06/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.